Replication At DNA Damage Sites Highlights Fanconi Anemia And Breast Cancer Proteins

While Fanconi anemia is a rare and dangerous disease, new laboratory research shows it may lead researchers toward clues in more common diseases, including highly hereditary types of breast cancer.
Full article >>

Genes identified may help breast cancer diagnosis

Researchers at Keele University, Germany, have identified two genes which may help improve the diagnosis and treatment of breast cancer patients.
Full article >>

The Way You Eat May Affect Your Risk For Breast Cancer

How you eat may be just as important as how much you eat, if mice studies are any clue. Cancer researchers have long studied the role of diet on breast cancer risk, but results to date have been mixed. New findings suggest the method by which calories are restricted may be more important for cancer protection than the actual overall degree of calorie restriction.
Full article >>

Stem Cell 'Daughters' Lead To Breast Cancer

Scientists have found that a population of breast cells called luminal progenitor cells are likely to be responsible for breast cancers that develop in women carrying mutations in the gene BRCA1.
Full article >>

The way you eat may affect your risk for breast cancer

How you eat may be just as important as how much you eat, if mice studies are any clue.
Full article >>

Stem cell 'daughters' lead to breast cancer

Walter and Eliza Hall Institute scientists have found that a population of breast cells called luminal progenitor cells are likely to be responsible for breast cancers that develop in women carrying mutations in the gene BRCA1.
Full article >>

Breast Cancer Hormone Receptor Status And Risk Of A Second Primary Tumor

Women with hormone receptor negative first tumors have twice as much risk for developing a second breast cancer as women with HR-positive tumors, according to a new study.
Full article >>

Could Therapeutic Vaccines Treat Hard-To-Beat Breast Cancers?

A comprehensive analysis of nearly 1,600 tumor samples has found that CT-X genes are expressed in nearly half the breast cancers that lack the estrogen receptor. CT-X gene products are the targets of therapeutic cancer vaccines already in phase III clinical trials for lung cancer and melanoma.
Full article >>

Chinese women join global breast cancer trial

Breast cancer patients have for the first time been recruited from China to take part in an international trial of breast radiotherapy.
Full article >>

One Gene That Contributes To Breast Cancer's Aggressive Behavior Identified

Scientists have identified a gene, known as RCP (or RAB11FIP1), that is frequently amplified and over-expressed in breast cancer, and functionally contributes to aggressive breast cancer behavior.
Full article >>

Breast Cancer Prognosis

Scientists have identified a stromal marker for breast cancer progression. 
Full article >>

Breast Cancer Drug Shows Promise Against Serious Infections

An FDA-approved drug used for preventing recurrence of breast cancer shows promise in fighting life-threatening fungal infections common in immune-compromised patients, such as infants born prematurely and patients with cancer.
Full article >>

Breast cancer drug shows promise against serious infections

An FDA-approved drug used for preventing recurrence of breast cancer shows promise in fighting life-threatening fungal infections common in immune-compromised patients, such as infants born prematurely and patients with cancer. Some scientists suspected that tamoxifen has antifungal properties; now new research from the University of Rochester Medical Center shows that it actually kills fungus cells and stops them from causing disease.
Full article >>

Targeting Specific Proteins To Halt Advanced Metastatic Breast Cancer

Two specific matrix metalloproteinase (MMP) proteins have been found to contribute to bone metastasis in advanced breast cancer -- lending important new insight into the design of clinically useful small molecule inhibitors.
Full article >>

Asian Spice Could Reduce Breast Cancer Risk In Women Exposed To Hormone Replacement Therapy

Previous studies have found that post-menopausal women who have taken a combined estrogen and progestin hormone replacement therapy have increased their risk of developing progestin-accelerated breast tumors. Now researchers have found that curcumin, a popular Indian spice derived from the turmeric root, could reduce the cancer risk for women after exposure to hormone replacement therapy.
Full article >>

DACH1 a key protein for tumor suppression in ER+ breast cancer

Researchers from the Kimmel Cancer Center at Jefferson have identified a protein relationship that may be an ideal treatment target for ER+ breast cancer. The study was reported in the July 15 issue of Cancer Research.
Full article >>

Asian spice could reduce breast cancer risk in women exposed to hormone replacement therapy

Previous studies have found that postmenopausal women who have taken a combined estrogen and progestin hormone replacement therapy have increased their risk of developing progestin-accelerated breast tumors. Now, University of Missouri researchers have found that curcumin, a popular Indian spice derived from the turmeric root, could reduce the cancer risk for women after exposure to hormone replacement therapy.
Full article >>

Elevated Insulin Linked To Increased Breast Cancer Risk

Elevated insulin levels in the blood appear to raise the risk of breast cancer in post-menopausal women, according to new research.
Full article >>

Newly Appreciated Membrane Estrogen Receptor Important Therapeutic Target For Breast Cancer

New research has uncovered the biological effects of a novel membrane estrogen receptor, a finding that has potential implications for hormonal therapy for breast cancer.
Full article >>

Are breast cancer patients being kept in the dark?

Despite the increase of breast reconstruction procedures performed in 2008, nearly 70 percent of women who are eligible for the procedure are not informed of the reconstructive options available to them, according to a recently published report. Newly released statistics by the American Society of Plastic Surgeons (ASPS) shows there were more than 79,000 breast reconstruction procedures performed in 2008 - a 39 percent increase over 2007. But in spite of this, current research suggests that many breast cancer patients are missing out on a key conversation that should take place at the time of diagnosis.
Full article >>